Brain Research Center Amsterdam B.V. — Clinical Trial Site

31 Registered trials

14 Currently recruiting

Organisation

Brain Research Center Amsterdam B.V.

Location

Amsterdam, Netherlands

Identifier

ORG-100043295

Address

Cronenburg 2, 1081 GN, Netherlands

Departments

-
Alzheimer centra
Brain center
Brain Research Center
Brain Research Center Amsterdam
Brain Research Center Amsterdam / VUMC
Brain Research Center Amsterdam B.V.
Brain Research centrum
Department of Neurology
Locatie Amsterdam
N/A
NA
Neurology
Psychiatry
Research
Research Facility

Clinical trials at this site (31)

Search interface

A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised

2022-501644-15-00 Mild Cognitive Impairment due to Alzheimer's Disease Al 4
A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Not authorised

2023-503631-18-00 Nervous system diseases 5
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending

2025-521113-13-00 Early Parkinson’s Disease 10
A Phase 1, Randomized, Placebo-controlled Study with a Double-blind Period with Open-label Extension Period to Evaluate the Safety, Tolerabi… Pending

2025-522582-30-00 Alzheimer’s Disease 1
First-in-Human Study of RO7812653 Recruiting

2025-522101-37-00 Early Symptomatic Alzheimer’s Disease (eAD), (Mild Cogn 1 2026-02-17
Long-term study to assess the safety and tolerability of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD) Recruiting

2024-519423-24-00 Major Depressive Disorder 5 2025-10-07
Randomised, double-blind, placebo-controlled study to assess safety and efficacy of PRI-002 in patients with MCI or mild dementia due to Alz… Recruiting

2022-503148-41-00 Alzheimer's disease 4 2023-12-01
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants with Early Alzheimer’s Diseas… Recruiting

2025-523515-11-00 Early Alzheimer's Disease 1 2026-04-03
A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease Recruiting

2024-516966-12-00 Alzheimer’s disease 4 2026-02-13
A Study to Compare the Efficacy and Safety of Prasinezumab with a placebo in Participants with Early-Stage Parkinson’s Disease Recruiting

2025-522683-32-00 Early-Stage Parkinson’s Disease (PD) 5 2026-01-15
A Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD) Recruiting

2024-518008-33-00 Early Symptomatic Alzheimer’s Disease (MCI to Mild Deme 5 2025-11-12
A Phase 3 Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer’s Disease Recruiting

2025-520747-32-00 Mild to moderate Alzheimer’s Disease 5 2025-10-29
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
A clinical study of MK-2214 in people with Alzheimer’s disease (MK-2214-004) Recruiting

2024-519190-19-00 Alzheimer’s Disease 4 2025-10-03
A Study to Evaluate the Efficacy, Safety and Tolerability of ALN-APP in Patients with Cerebral Amyloid Angiopathy (CAA) Recruiting

2023-510137-29-01 Cerebral Amyloid Angiopathy (CAA) is a neurological con 4 2025-04-09
A Phase 2a, dose-finding, randomized, double-blinded, placebo-controlled study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safet… Recruiting

2023-509613-37-01 Alzheimer's Disease 9 2024-10-08
A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s dise… Recruiting

2024-511110-21-00 Parkinson’s Disease 1 2024-09-09
A First-in-Human Study to Evaluate the Safety and Tolerability of ALN-APP in Patients with EOAD Recruiting

2023-508363-79-00 Early-onset Alzheimer's disease (EOAD) 1 2022-06-29
A Phase 3 Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants with Early Alzhei… Ended

2023-508306-15-00 Alzheimer’s Disease 5 2024-06-26
A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzhe… Ended

2022-501644-15-01 Mild Cognitive Impairment due to Alzheimer's Disease Al 4 2023-09-28
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Early… Ended

2024-515198-91-00 Dominantly Inherited Alzheimer Disease (DIAD) 10 2022-12-20
A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of MK-1167 as Adjunctive Th… Ended

2024-515539-31-00 Alzheimer’s disease dementia 4 2025-04-01
EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE Ended

2023-505083-11-01 Alzheimer's Disease 4 2024-05-07
A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD) Ended

2024-511770-76-00 Alzheimer's disease 1 2023-10-31